StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Quest Diagnostics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Quest Diagnostics's price to sales ratio was 2.5× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 1.4× to 2.5×, with a median of 1.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×+0.7
2025Dec 31, 20251.8×+0.1
2024Dec 31, 20241.8×+0.1
2023Dec 29, 20231.7×−0.1
2022Dec 30, 20221.8×−0.2
2021Dec 31, 20212.0×+0.1
2020Dec 31, 20201.9×+0.0
2019Dec 31, 20191.9×+0.4
2018Dec 31, 20181.5×−0.3
2017Dec 29, 20171.9×+0.1
2016Dec 30, 20161.8×+0.4
2015Dec 31, 20151.4×+0.0
2014Dec 31, 20141.3×+0.2
2013Dec 31, 20131.2×−0.1
2012Dec 31, 20121.3×+0.2
2011Dec 30, 20111.0×−0.3
2010Dec 31, 20101.3×+0.2
2009Dec 31, 20091.2×–

More Quest Diagnostics figures

See a number that looks wrong?